Llwytho...
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
AIM: To evaluate the association between alpha-1 antitrypsin deficiency (A1ATD) and hepatocellular carcinoma (HCC) in patients with end-stage liver disease (ESLD). METHODS: Patients with cirrhosis and ESLD referred to the Cleveland Clinic Foundation for liver transplantation between 2003 and 2014 we...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | World J Hepatol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Baishideng Publishing Group Inc
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4450206/ https://ncbi.nlm.nih.gov/pubmed/26052388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i10.1427 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|